Browse by Condition in Denver
And 44 more conditions with trials in Denver
Recruiting Clinical Trials in Denver
NCT06073431 · University of Rochester
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT07097142 · Phase 3 · NRG Oncology
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NCT06952660 · Phase 4 · Pfizer
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
NCT06872892 · Phase 3 · Boehringer Ingelheim
The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT05640999 · Phase 2 · Canadian Cancer Trials Group
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
NCT07388498 · Phase 3 · Amgen
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
NCT04097145 · Edwards Lifesciences
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT06059638 · Orchestra BioMed, Inc
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT01656603 · Phase 2 · New York Blood Center
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
NCT06388421 · United Therapeutics
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06504589 · Nicole Hamblett
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06103864 · Phase 3 · AstraZeneca
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
Top Study Sponsors in Denver
| Sponsor | Recruiting studies |
|---|---|
| University of Colorado, Denver | 20 |
| AstraZeneca | 12 |
| Eli Lilly and Company | 10 |
| Novartis Pharmaceuticals | 10 |
| Janssen Research & Development, LLC | 7 |
| AbbVie | 6 |
| Merck Sharp & Dohme LLC | 6 |
| National Jewish Health | 6 |
Trials in Denver by Phase
| Phase | Studies |
|---|---|
| Early Phase 1 | 2 |
| Phase 1 | 78 |
| Phase 1/2 | 55 |
| Phase 2 | 61 |
| Phase 2/3 | 10 |
| Phase 3 | 60 |
| Phase 4 | 12 |
| Not phased | 123 |
32 of these studies accept healthy volunteers.
Clinical Trials in Denver: Common Questions
How many clinical trials are recruiting in Denver, CO?
401 clinical trials list a recruiting site in Denver, CO, across 74 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Denver?
The most active research areas in Denver right now are advanced solid tumors, multiple myeloma, leukemia. Browse by condition above to see each study.
Who sponsors clinical trials in Denver?
The sponsors with the most recruiting studies in Denver include University of Colorado, Denver, AstraZeneca, Eli Lilly and Company.
Are there clinical trials for healthy volunteers in Denver?
Yes. 32 of the recruiting studies in Denver accept healthy volunteers.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Denver, CO
Denver, CO is home to 401 actively recruiting clinical trials across 74 medical conditions as of 2026. The most active research areas include advanced solid tumors, multiple myeloma, leukemia. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.